Use of botulinum toxin a in treatment of blepharospasm
Balcewicz, I.; Dewachter, A.
Klinika Oczna 95(8): 316-319
1993
ISSN/ISBN: 0023-2157 PMID: 8189695 Document Number: 416071
Retrospective examinations comprised 26 patients with idiopathic, spastic blepharospasm, who received injections of botulinum A toxin subcutaneously or into orbicular muscle of eye. In 6 cases complete recovery was achieved. In all patients, symptoms subsided for a mean period of 12.5 weeks. These results are similar to those described earlier in literature.
Document emailed within 1 workday
Related Documents
Cibis, G.W.; Waeltermann, J. 1985: Botulinum isn't just a poison anymore. Botulinum toxin in treatment of strabismus and essential blepharospasm Missouri Medicine 82(3): 145-147Elston, J.S. 1988: Botulinum toxin treatment of blepharospasm Advances in Neurology 50: 579-581
Bihari, K. 1988: Treatment of blepharospasm with botulinum A toxin injections Orvosi Hetilap 129(2): 67-68
Poungvarin, N.; Devahastin, V.; Chaisevikul, R.; Prayoonwiwat, N.; Viriyavejakul, A. 1997: Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients Journal of the Medical Association of Thailand 80(1): 1-8
Tsai, C.-P.; Chiu, M.-C.; Yen, D.-J.; Guo, Y.-C.; Yuan, C.-L.; Lee, T.-C. 2005: Quantitative assessment of efficacy of dysport (botulinum toxin type A) in the treatment of idiopathic blepharospasm and hemifacial spasm Acta Neurologica Taiwanica 14(2): 61-68
Iwashige, H.; Nemeto, Y.; Takahashi, H.; Maruo, T. 1995: Botulinum toxin type a purified neurotoxin complex for the treatment of blepharospasm: a dose-response study measuring eyelid force Japanese Journal of Ophthalmology 39(4): 424-431
Prutthipongsit, A.; Aui-aree, N. 2015: The Difference of Treatment Results between Botulinum Toxin a Split Injection Sites and Botulinum Toxin a Non-Split Injection Sites for Hemifacial Spasm Journal of the Medical Association of Thailand 98(11): 1119-1123
Anosov, I.I.; Bulatova, T.I. 1983: Morphological and histochemical reactions of an organism to the administration of Clostridium botulinum toxin. IX. Reactions of the neurons of the abducens nerve nucleus and of the Darkshevich's nucleus to the administration of C. botulinum type B toxin Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2: 101-105
Rodríguez Cruz, E.; Sheehan, C.; Fraiberg, E.; Hasan, S. 1997: Botulinum toxin a for the treatment of achalasia Boletin de la Asociacion Medica de Puerto Rico 89(4-6): 57-59
Ruusuvaara, P.; Setälä, K. 1991: Treatment of facial spasm using botulinum toxin Duodecim; Laaketieteellinen Aikakauskirja 107(19): 1627-1629
Duzyński, W.; Sławek, J. 1998: Treatment of hemifacial spasm with botulinum a toxin Neurologia i Neurochirurgia Polska 32(Suppl 1): 61-69
Ward, A.B. 2008: Botulinum toxin in spasticity treatment in adults Der Nervenarzt 79(Suppl 1): 22-23
Sojer, M.; Wissel, J.; Müller, J.; Poewe, W. 2001: Treatment of focal dystonia with botulinum toxin a Wiener Klinische Wochenschrift 113(Suppl 4): 6-10
Tjaberg, T.B. 1974: Proteases of Clostridium botulinum. VI. the role of trypsin, Clostridium botulinum proteases and protease inhibitors in the formation and activation of toxin in growing cultures of Clostridium botulinum Acta Veterinaria Scandinavica 15(4): 487-506
Simpson, L.L. 1984: The binding fragment from tetanus toxin antagonizes the neuromuscular blocking actions of botulinum toxin Journal of Pharmacology and Experimental Therapeutics 229(1): 182-187
BinSaif, G.A.; Al Samary, A.; Al Mohizea, S. 2010: Failure of botulinum toxin treatment for localized vitiligo Journal of Drugs in Dermatology: Jdd 9(9): 1092-1094
Al-Ahmad, H.T.; Al-Qudah, M.A. 2006: The treatment of masseter hypertrophy with botulinum toxin type A Saudi Medical Journal 27(3): 397-400
Chuang, Y-Chi.; Smith, C.P.; Somogyi, G.T.; Chancellor, M.B. 2003: Botulinum toxin treatment of urethral and bladder dysfunction Journal of the Formosan Medical Association 102(1): 5-11
Comella, C.L.; Jankovic, J.; Brin, M.F. 2000: Use of botulinum toxin type a in the treatment of cervical dystonia Neurology 55(12 Suppl 5: S15-S21
Thompson, A.R. 1994: Botulinum toxin in the treatment of adductor spasmodic dysphonia Journal of the Arkansas Medical Society 90(8): 383-385